Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 233,432,843 papers from all fields of science
Search
Sign In
Create Free Account
somatostatin receptor 5
Known as:
somatostatin receptor-5
, SSTR5 receptor
, Somatostatin Receptor Subtype 5
Expand
Somatostatin receptor type 5 (364 aa, ~39 kDa) is encoded by the human SSTR5 gene. This protein is involved in somatostatin-dependent G protein…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
14 relations
Cell Proliferation Regulatory Process
G Protein-Coupled Receptor Genes
G Protein-Coupled Receptor Signaling
Integral Membrane Proteins
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Evaluation of the expression of somatostatin receptors by immunohistochemistry in neuroendocrine tumors of the small intestine.
P. Gut
,
A. Czarnywojtek
,
+6 authors
M. Ruchała
Polish journal of pathology : official journal of…
2020
Corpus ID: 218755045
Most neuroendocrine neoplasms (NEN) are characterized by the presence of somatostatin receptors (SSTR) which we use in location…
Expand
Review
2018
Review
2018
δ-Cells Make in Glucose Control.
Mark
,
Ó.
,
+11 authors
G. Noguchi
2018
Corpus ID: 54185589
The role of beta and alpha cells to glucose control are established, but the physiological role of delta cells is poorly…
Expand
2016
2016
Immunohistochemical expression of somatostatin receptor subtypes 2 and 5 in thyrotropin-secreting pituitary adenomas : a consecutive case series of pituitary adenomas
Hong-juan Fang
,
Yang-Fang Li
,
Yu Fu
,
L. Zhong
,
Ya-zhuo Zhang
2016
Corpus ID: 10225261
Thyrotropin-secreting pituitary adenomas (TSHomas) are a rare cause of hyperthyroidism. Somatostatin analogue has proved to be…
Expand
2008
2008
Erfolgreiche Behandlung einer lebensbedrohlichen Ileostoma-Diarrhoe mit dem Somatostatin-Analogon Octreotid
B. Neef
,
E. Höring
,
U. Gaisberg
2008
Corpus ID: 72897877
: A 72-year-old man with Crohn's disease for about 6 years was urgently hospitalized in hypovolaemic shock. On admission, serum…
Expand
2008
2008
Somatostatin Receptors Subtypes 2 and 5 , Dopamine Receptor Type 2 Expression and gsp Status as Predictors of Octreotide LAR ® Responsiveness in Acromegaly
V. Neto
2008
Corpus ID: 33367431
We present two acromegalic patients in which clinical and molecular data are discussed in regard to their ability to predict long…
Expand
2001
2001
Therapie der endokrinen Orbitopathie mit Somatostatin‐Analoga bei Patienten mit positivem Octreo‐Scan
R. Pichler
,
W. Maschek
,
C. Holzinger
2001
Corpus ID: 73218099
We prospectively evaluated 28 persons with active endocrine ophthalmopathy and positive sonographic criteria (A-mode) on…
Expand
2000
2000
Diagnostische Abklärung eines TSH-produzierenden Hypophysenadenoms bei » Empty Sella « mittels Somatostatin-und Dopamin-D2-Rezeptorszintigraphie
F. Berger
,
G. Meyer
,
+4 authors
K. Hahn
2000
Corpus ID: 77884025
2000
2000
Evaluation von Diagnosevorschriften mittels interkategorieller kappa-Maße
F. Krummenauer
Der Radiologe
2000
Corpus ID: 32288522
ZusammenfassungEs wird ein Studiendesign beschrieben, welches die empirische Bewertung neu vorgeschlagener diagnostischer…
Expand
1999
1999
Untersuchungen zum Somatostatinrezeptor-Status bei nicht-medullären Schilddrüsenkarzinomen
R. Gorges
,
G. Kahaly
,
+6 authors
A. Bockisch
Nuklearmedizin
1999
Corpus ID: 74020957
Zusammenfassung Ziel: In aktuellen ln-vitro- und In-vivo-Untersuchungen wurde eine Somatostatinrezeptor-Expression bei einigen…
Expand
1999
1999
Somatostatinrezeptorszintigraphie bei einem Patienten mit invasivem Makroprolaktinom
P. Meyer
,
Nicolaas I. Bohnen
,
A. L. Barkan
,
B. Shapiro
1999
Corpus ID: 75527458
A 41-year-old with a giant prolactinoma underwent ln-111 pentetreotide (Octreotide) imaging showing very intense tracer uptake in…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE